Sexual dynamics as a critical part in the individualised management of men with erectile dysfunction in UK
Hassan, TA1; Donde, S.2
1: Pfizer Inc, USA; 2: Pfizer Inc, United Kingdom
Objective: There is a paucity of information on the integration of sexual dynamics in managing men with ED in the United Kingdom. The study was designed to gather the pertinent data on sexual habits and behaviours of men with ED in UK.
Method: Between 2nd December 2016 and 6th January 2017; an independent market research company conducted an online survey in men aged 40-70 years. Upon passing specific screening criteria, eligible respondents who were self- diagnosed based on the Erection Hardness score of 1, 2 or 3 and have taken ED medication in the last 3 months completed the online self-administered survey.
The survey comprised mainly of questions on advance planning of sexual intercourse, number of times of sexual encounters per month, time between taking an ED medication and indulging in sexual intercourse and the presence of comorbid conditions.
Results: Of the 349 men with ED,, 76% always or sometimes plan in advance for sexual intercourse and 79 % of men who planned, did so several hours in advance. Interestingly, 38% planned sexual intercourse on specific days of the week and 61% on particular times of the day. Moreover the findings revealed that frequency of sexual intercourse of men with ED was on average 6 times per month and 89% of men with ED have sexual intercourse within four hours of taking ED medication. The overall rates of comorbid conditions in men with ED were high: hypercholesterolemia 42%, hypertension 42% and diabetes mellitus 22%.
Conclusions: For the population assessed in this study, most men with ED plan sexual intercourse ahead of the encounter, most up to several hours in advance and nearly all take their medication within a few hours of sexual activity. Hypercholesterolemia, hypertension and diabetes mellitus were found to be the most common comorbid conditions with ED and this offers a good opportunity for cardiovascular risk mitigation in men with ED in UK. In clinical practice setting, a thorough understanding of patients’ sexual dynamics, risk factors and treatment goals can assist healthcare providers in individualizing the management of ED.
Work supported by industry: yes, by Pfizer Inc (no industry support in study design or execution). The presenter or any of the authors act as a consultant, employee (part time or full time) or shareholder of an industry.Go Back